Results 31 to 40 of about 11,066 (220)

Psychedelics as a Treatment for Alzheimer’s Disease Dementia

open access: yesFrontiers in Synaptic Neuroscience, 2020
Currently, there are no disease-modifying treatments for Alzheimer’s disease (AD) or any other dementia subtype. The renaissance in psychedelic research in recent years, in particular studies involving psilocybin and lysergic acid diethylamide (LSD ...
Simon Andrew Vann Jones   +1 more
doaj   +1 more source

MDLSD: study protocol for a randomised, double-masked, placebo-controlled trial of repeated microdoses of LSD in healthy volunteers

open access: yesTrials, 2021
Background Regular ingestion of sub-hallucinogenic doses of psychedelics, referred to as “microdosing”, has gained increasing popularity and attention in the press and in online forums, with reported benefits across multiple cognitive and emotional ...
Robin J. Murphy   +10 more
doaj   +1 more source

Alterations of consciousness and mystical-type experiences after acute LSD in humans [PDF]

open access: yes, 2016
Lysergic acid diethylamide (LSD) is used recreationally and in clinical research. Acute mystical-type experiences that are acutely induced by hallucinogens are thought to contribute to their potential therapeutic effects.
Dolder, Patrick C.   +2 more
core   +2 more sources

LSD degrades hippocampal spatial representations and suppresses hippocampal-visual cortical interactions

open access: yesCell Reports, 2021
Summary: Lysergic acid diethylamide (LSD) produces hallucinations, which are perceptions uncoupled from the external environment. How LSD alters neuronal activities in vivo that underlie abnormal perceptions is unknown.
Carli Domenico   +3 more
doaj   +1 more source

Shannon entropy of brain functional complex networks under the influence of the psychedelic Ayahuasca [PDF]

open access: yes, 2016
The entropic brain hypothesis holds that the key facts concerning psychedelics are partially explained in terms of increased entropy of the brain's functional connectivity.
de Araujo, Draulio B.   +4 more
core   +6 more sources

Intoxication of dogs and cats with common stimulating, hallucinogenic and dissociative recreational drugs

open access: yesVeterinary and Animal Science, 2023
Pets can have accidental, intentional, or malicious exposure to illicit drugs. It is a growing concern over the last decade because there is an increase in usage of illicit drugs in humans and diagnosis is difficult.
Ena Oster   +6 more
doaj   +1 more source

Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases [PDF]

open access: yes, 2014
A double-blind, randomized, active placebo-controlled pilot study was conducted to examine safety and efficacy of lysergic acid diethylamide (LSD)-assisted psychotherapy in 12 patients with anxiety associated with life-threatening diseases.
Brenneisen, Rudolf   +6 more
core   +2 more sources

Mycotherapy: Potential of Fungal Bioactives for the Treatment of Mental Health Disorders and Morbidities of Chronic Pain

open access: yesJournal of Fungi, 2022
Mushrooms have been used as traditional medicine for millennia, fungi are the main natural source of psychedelic compounds. There is now increasing interest in using fungal active compounds such as psychedelics for alleviating symptoms of mental health ...
Elaine Meade   +3 more
doaj   +1 more source

Histoire du LSD. De l’ergot de seigle à l’utilisation thérapeutique [PDF]

open access: yes, 2015
National audienceLe LSD, de l’allemand Lysergsäurediethylamid, est une substance hallucinogène utilisée à but récréatif. Également connue sous le nom d’« acide », cette molécule à propriétés psychotropes est classée en France comme un stupéfiant illicite
Gicquel, Thomas   +2 more
core   +3 more sources

Inhibition of alpha oscillations through serotonin-2A receptor activation underlies the visual effects of ayahuasca in humans [PDF]

open access: yes, 2016
Ayahuasca is an Amazonian psychotropic plant tea typically obtained from two plants, Banisteriopsis caapi and Psychotria viridis. It contains the psychedelic 5-HT2A and sigma-1 agonist N,N-dimethyltryptamine (DMT) plus ß-carboline alkaloids with ...
Alonso, Joan Francesc   +12 more
core   +3 more sources

Home - About - Disclaimer - Privacy